| 69 |
Cardiogenic Shock: the Role of Cath-Lab Team |
Young Seo Lee |
May. 26. 25 |
| 68 |
VARIANT-ICD Trial: ICD vs. Medical Therapy Alone in Variant Angina With Aborted SCD |
Do-Yoon Kang |
Apr. 17. 25 |
| 67 |
Mechanical Circulatory Support in High-Risk PE |
David Joel Cohen |
Apr. 17. 25 |
| 66 |
Controversies in Medical Therapy for Ischemic Cardiomyopathy |
Jeehoon Kang |
Apr. 17. 25 |
| 65 |
Management Strategies for Severe Ischemic Heart Disease: When CABG Is Not an Option |
Imad Sheiban |
Apr. 17. 25 |
| 64 |
PCI in Ischemic Cardiomyopathy: Current & Future Perspectives |
Joo Myung Lee |
Apr. 17. 25 |
| 63 |
CABG in Patients With Impaired Ventricular Function: Indications and Outcomes |
David Paul Taggart |
Apr. 17. 25 |
| 62 |
Interatrial Shunt Treatment for Heart Failure |
Gregg W. Stone |
Apr. 17. 25 |
| 61 |
Real-World Experience With the Impella Use in Japan |
Junya Ako |
Apr. 17. 25 |
| 60 |
Revascularization Strategies in Cardiogenic Shock |
Jeong Hoon Yang |
Apr. 17. 25 |
